G. Heinzel

1.2k total citations
31 papers, 913 citations indexed

About

G. Heinzel is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, G. Heinzel has authored 31 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 9 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in G. Heinzel's work include Inflammatory mediators and NSAID effects (13 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). G. Heinzel is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacogenetics and Drug Metabolism (6 papers). G. Heinzel collaborates with scholars based in Germany, Switzerland and United Kingdom. G. Heinzel's co-authors include Ulrich Busch, H. Narjes, Dominique Turck, Jochen Schmid, W. Roth, Gerhard Nehmiz, G Kleinberger, Wilfred Druml, G Bozler and K Beschke and has published in prestigious journals such as American Journal of Clinical Nutrition, Journal of Pharmaceutical Sciences and Journal of Antimicrobial Chemotherapy.

In The Last Decade

G. Heinzel

31 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Heinzel Germany 16 391 211 156 136 83 31 913
Fakhreddin Jamali Canada 20 574 1.5× 318 1.5× 240 1.5× 188 1.4× 98 1.2× 39 1.4k
W. Roth Germany 10 227 0.6× 102 0.5× 114 0.7× 73 0.5× 46 0.6× 18 647
Thomas M. Twomey United States 16 269 0.7× 146 0.7× 182 1.2× 72 0.5× 52 0.6× 20 730
Timothy J. Maziasz United States 15 718 1.8× 220 1.0× 255 1.6× 112 0.8× 67 0.8× 21 1.4k
J. Godbillon Switzerland 24 286 0.7× 188 0.9× 107 0.7× 168 1.2× 53 0.6× 61 1.3k
M. D. Chaplin United States 17 361 0.9× 311 1.5× 186 1.2× 151 1.1× 155 1.9× 36 1.1k
J. W. Faigle Switzerland 19 372 1.0× 403 1.9× 221 1.4× 251 1.8× 40 0.5× 48 1.3k
Peter H. Hinderling United States 19 186 0.5× 200 0.9× 252 1.6× 189 1.4× 106 1.3× 48 1.1k
Anthony S. Ridolfo United States 16 258 0.7× 188 0.9× 83 0.5× 69 0.5× 55 0.7× 31 687
Harvey M. Solomon United States 24 272 0.7× 264 1.3× 513 3.3× 234 1.7× 127 1.5× 76 1.7k

Countries citing papers authored by G. Heinzel

Since Specialization
Citations

This map shows the geographic impact of G. Heinzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Heinzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Heinzel more than expected).

Fields of papers citing papers by G. Heinzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Heinzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Heinzel. The network helps show where G. Heinzel may publish in the future.

Co-authorship network of co-authors of G. Heinzel

This figure shows the co-authorship network connecting the top 25 collaborators of G. Heinzel. A scholar is included among the top collaborators of G. Heinzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Heinzel. G. Heinzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Druml, Wilfred, G. Heinzel, & G Kleinberger. (2001). Amino acid kinetics in patients with sepsis. American Journal of Clinical Nutrition. 73(5). 908–913. 85 indexed citations
2.
Busch, Ulrich, G. Heinzel, & Gerhard Nehmiz. (2000). Precision of Measurement of Tissue Concentrations by RLG. Regulatory Toxicology and Pharmacology. 31(2). S45–S50. 7 indexed citations
3.
Turck, Dominique, et al.. (2000). Steady‐state pharmacokinetics of lithium in healthy volunteers receiving concomitant meloxicam. British Journal of Clinical Pharmacology. 50(3). 197–204. 17 indexed citations
4.
Drewe, Jürgen, et al.. (2000). Absorption of lefradafiban from different sites of the gastrointestinal tract. British Journal of Clinical Pharmacology. 50(1). 69–72. 11 indexed citations
5.
Heinzel, G., et al.. (1999). Disposition and Chemical Stability of Telmisartan 1-O-Acylglucuronide. Drug Metabolism and Disposition. 27(10). 1143–1149. 82 indexed citations
6.
Busch, Ulrich, et al.. (1998). Pharmacokinetics of meloxicam in animals and the relevance to humans.. PubMed. 26(6). 576–84. 196 indexed citations
7.
Turck, Dominique, et al.. (1997). Lack of interaction between meloxicam and warfarin in healthy volunteers. European Journal of Clinical Pharmacology. 51(5). 421–425. 19 indexed citations
8.
Boulton‐Jones, J. M., Colin Geddes, G. Heinzel, et al.. (1997). Meloxicam pharmacokinetics in renal impairment. British Journal of Clinical Pharmacology. 43(1). 35–40. 12 indexed citations
9.
Heinzel, G., et al.. (1997). PK/PD simulations as a tool for rational design of clinical dosage regimens: an example with Fradafiban.. PubMed. 35(10). 475–80. 1 indexed citations
10.
Turck, Dominique, Ulrich Busch, G. Heinzel, & H. Narjes. (1997). Clinical pharmacokinetics of meloxicam.. PubMed. 47(3). 253–8. 64 indexed citations
11.
Narjes, H., Dominique Turck, Ulrich Busch, G. Heinzel, & Gerhard Nehmiz. (1996). Pharmacokinetics and tolerability of meloxicam after i.m. administration. British Journal of Clinical Pharmacology. 41(2). 135–139. 27 indexed citations
12.
Busch, Ulrich, G. Heinzel, H. Narjes, & Gerhard Nehmiz. (1996). Interaction of Meloxicam with Cimetidine, Maalox, or Aspirin. The Journal of Clinical Pharmacology. 36(1). 79–84. 33 indexed citations
13.
Turck, Dominique, Albin Schwarz, D Höffler, et al.. (1996). Pharmacokinetics of meloxicam in patients with end-stage renal failure on haemodialysis: a comparison with healthy volunteers. European Journal of Clinical Pharmacology. 51(3-4). 309–313. 14 indexed citations
14.
Busch, Ulrich, G. Heinzel, & H. Narjes. (1995). The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man. European Journal of Clinical Pharmacology. 48-48(3-4). 269–72. 28 indexed citations
15.
Roth, W., et al.. (1993). Zatebradine: Pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects. Journal of Pharmaceutical Sciences. 82(1). 99–106. 19 indexed citations
16.
Busch, Ulrich, G. Heinzel, & H. Narjes. (1991). Effect of food on pharmacokinetics of meloxicam, a new non steroidal anti-inflammatory drug (NSAID). Inflammation Research. 32(1-2). 52–53. 15 indexed citations
17.
Digel, W., et al.. (1991). Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-γ in cancer patients. Cancer Immunology Immunotherapy. 34(3). 169–174. 5 indexed citations
18.
Heinzel, G., et al.. (1985). [Results of bacteriologic studies on sudden unexpected infant death with special reference to infant botulism].. PubMed. 43. 378–80. 1 indexed citations
19.
Heinzel, G., et al.. (1977). [Model building in pharmacokinetics/Part IV: Derivation of microconstants in linear compartment models (author's transl)].. PubMed. 27(4a). 912–28. 1 indexed citations
20.
Heinzel, G., et al.. (1977). [Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)].. PubMed. 27(4a). 904–11. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fakhreddin Jamali Breakdown of academic impact, for papers by W. Roth Breakdown of academic impact, for papers by Thomas M. Twomey Breakdown of academic impact, for papers by Timothy J. Maziasz Breakdown of academic impact, for papers by J. Godbillon Breakdown of academic impact, for papers by M. D. Chaplin Breakdown of academic impact, for papers by J. W. Faigle Breakdown of academic impact, for papers by Peter H. Hinderling Breakdown of academic impact, for papers by Anthony S. Ridolfo Breakdown of academic impact, for papers by Harvey M. Solomon
Rankless by CCL
2026